SavedAdd your journal

Journals / Turkish Journal of Cancer / 2000 / Cilt: 30 - Sayı: 3

Small cell carcinoma of the prostate: Report of two cases

Sinan SÖZEN
AYTUĞ ÜNER
Turgut ALKİBAY
Pages
131–134
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

One was seen as an initial event at the time of first diagnosis and the other was seen as a late event superimposed on the clinical history of advanced prostate cancer.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Small cell carcinoma of the prostate is a rare pathologic subtype of prostate cancer with unique clinical features.
📊
Key Findings & Data:This report describes two cases of small cell carcinoma of the prostate in two clinical settings.
💡
Conclusion & Impact:One was seen as an initial event at the time of first diagnosis and the other was seen as a late event superimposed on the clinical history of advanced prostate cancer.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Neoplazm metastazı · Prostat neoplazmları · Hücre farklılaşması

Abstract

Small cell carcinoma of the prostate is a rare pathologic subtype of prostate cancer with unique clinical features. This report describes two cases of small cell carcinoma of the prostate in two clinical settings. One was seen as an initial event at the time of first diagnosis and the other was seen as a late event superimposed on the clinical history of advanced prostate cancer.

Özet

Small cell carcinoma of the prostate is a rare pathologic subtype of prostate cancer with unique clinical features. This report describes two cases of small cell carcinoma of the prostate in two clinical settings. One was seen as an initial event at the time of first diagnosis and the other was seen as a late event superimposed on the clinical history of advanced prostate cancer.

🔖

Cite This Article

SÖZEN, S., ÜNER, A., ALKİBAY, T. (2000). Small cell carcinoma of the prostate: Report of two cases. Turkish Journal of Cancer, Cilt: 30 - Sayı: 3, 131–134. https://ajindex.com/articles/368414

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Di Sant’ Agnese P. Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications. Cancer 1992;70:254-68
  2. Abrahamsson PA, Waldström LB, Aluments J, et al. Peptide-hormone and serotonin-immunoreactive tumor cells in carcinoma of the prostate. Pathol Res Pract 1987;182:298-307
  3. Aprikian AG, Cordon-Cardo L, Fair WR, et al. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer 1993;71:3952-6
  4. Helpap B, Köllermann J, Oehler U. Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectives. Urol Int 1999;62:133-8
  5. Aprikian AG, Cordon-Cardo L, Fair WR, et al. Neuroendocrine differentiation in metastatic prostatic carcinoma. J Urol 1994;251:914-9
  6. Ro JY, Tetu B, Ayala AG, et al. Small cell carcinoma of the prostate. II. Immunohistochemical and electron microscopic studies of 18 cases. Cancer 1987,59:977-82
  7. Mackey JR, Au HJ, Hugh J, et al. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival. J Urol 1998,159:1624-9.